139 related articles for article (PubMed ID: 27476455)
21. Identification of drugs inducing phospholipidosis by novel in vitro data.
Muehlbacher M; Tripal P; Roas F; Kornhuber J
ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
[TBL] [Abstract][Full Text] [Related]
22. Three new consensus QSAR models for the prediction of Ames genotoxicity.
Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
[TBL] [Abstract][Full Text] [Related]
23. Prediction of drug-related cardiac adverse effects in humans--B: use of QSAR programs for early detection of drug-induced cardiac toxicities.
Frid AA; Matthews EJ
Regul Toxicol Pharmacol; 2010 Apr; 56(3):276-89. PubMed ID: 19941924
[TBL] [Abstract][Full Text] [Related]
24. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
25. pH-gradient PAMPA-based in vitro model assay for drug-induced phospholipidosis in early stage of drug discovery.
Balogh GT; Müller J; Könczöl A
Eur J Pharm Sci; 2013 Apr; 49(1):81-9. PubMed ID: 23439241
[TBL] [Abstract][Full Text] [Related]
26. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities.
Matthews EJ; Ursem CJ; Kruhlak NL; Benz RD; Sabaté DA; Yang C; Klopman G; Contrera JF
Regul Toxicol Pharmacol; 2009 Jun; 54(1):23-42. PubMed ID: 19422098
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
[TBL] [Abstract][Full Text] [Related]
28. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
Valerio LG; Cross KP
Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
[TBL] [Abstract][Full Text] [Related]
29. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
[TBL] [Abstract][Full Text] [Related]
30. Establishment of an in silico phospholipidosis prediction method using descriptors related to molecular interactions causing phospholipid-compound complex formation.
Haranosono Y; Nemoto S; Kurata M; Sakaki H
J Toxicol Sci; 2016 Apr; 41(2):321-8. PubMed ID: 26961617
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.
Jolly R; Ahmed KB; Zwickl C; Watson I; Gombar V
Regul Toxicol Pharmacol; 2015 Apr; 71(3):388-97. PubMed ID: 25656493
[TBL] [Abstract][Full Text] [Related]
32. Predicting the mutagenic potential of chemicals in tobacco products using
Goel R; Valerio LG
Toxicol Mech Methods; 2020 Nov; 30(9):672-678. PubMed ID: 32752976
[TBL] [Abstract][Full Text] [Related]
33. Development of improved QSAR models for predicting the outcome of the in vivo micronucleus genetic toxicity assay.
Yoo JW; Kruhlak NL; Landry C; Cross KP; Sedykh A; Stavitskaya L
Regul Toxicol Pharmacol; 2020 Jun; 113():104620. PubMed ID: 32092371
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
[TBL] [Abstract][Full Text] [Related]
35. In Silico Screening of Chemicals for Genetic Toxicity Using MDL-QSAR, Nonparametric Discriminant Analysis, E-State, Connectivity, and Molecular Property Descriptors.
Contrera JF; Matthews EJ; Kruhlak NL; Benz RD
Toxicol Mech Methods; 2008; 18(2-3):207-16. PubMed ID: 20020915
[TBL] [Abstract][Full Text] [Related]
36. Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential.
Nath A; Sahu GK
J Theor Biol; 2019 Oct; 479():37-47. PubMed ID: 31310757
[TBL] [Abstract][Full Text] [Related]
37. Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities.
Fioravanzo E; Bassan A; Pavan M; Mostrag-Szlichtyng A; Worth AP
SAR QSAR Environ Res; 2012; 23(3-4):257-77. PubMed ID: 22369620
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the OECD (Q)SAR Application Toolbox and Toxtree for predicting and profiling the carcinogenic potential of chemicals.
Mombelli E; Devillers J
SAR QSAR Environ Res; 2010 Oct; 21(7-8):731-52. PubMed ID: 21120759
[TBL] [Abstract][Full Text] [Related]
39. Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds.
Hanumegowda UM; Wenke G; Regueiro-Ren A; Yordanova R; Corradi JP; Adams SP
Chem Res Toxicol; 2010 Apr; 23(4):749-55. PubMed ID: 20356072
[TBL] [Abstract][Full Text] [Related]
40. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
Miyamoto S; Matsumoto A; Mori I; Horinouchi A
Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
